Cingulate Inc   (CING)

caused great surprise for the stock market, exhibiting a significant rise in fiscal span ending September 30 2022 with operating deficit of $-3.968362 millions

CING reported fourth quarter of 2022 operating deficit of $-4.475195 millions

Published Mar 27 2023
Goran Soko / CSIMarket.com Contributer

Dryvax_pd While the earnings cycle of fiscal July to September 30 2022 goes on, the most companies have reported their numbers. In the thick of it, are several corporations in the Major Pharmaceutical Preparations sector. And today, CING published operating deficit of $-3.968362 millions, for the fiscal span closing Sep 30 2022.

It could be apparently viewed as good news, void of more convalescent benchmarks. The improvement from the operating deficit from the corresponding reporting period a year ago of $-17.501718 millions. It gives the most investors affirmation regarding CING.

Subsequently, there has been mitigation on the net loss. as the losses have been trimmed from the period, a year prior. It was a major verdict in the fiscal span ending third quarter of 2022. Deficit was $-4.027 millions, while in the third quarter of 2022 $-17.676 millions.

Cingulate Inc is expected to report next financial earnings on May 11, 2023.

Cingulate Inc's Net Income Growth

Cingulate Inc's ROI


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071